References
- Hallek M, Cheson BD, Catovsky D, et al. IWCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL. Blood. 2018;131(25):2745–2760.
- Swerdlow SH, Campo E, Pileri SA, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016;27(20):2375–2390.
- Schwartz JB, Shamsuddin AM. The effects of leukemia infiltrate in various organs in chronic lymphyocytic leukemia. Hum Pathol. 1980;12(5):432–440.
- Gordon MJ, Danilova O, Spurgeon S, et al. Cardiac non-Hodgkin’s lymphoma: clinical characteristics and trends in survival. Eur J Haematol. 2016;97(5):445–452.
- Patel J, Melly L, Sheppard MN. Primary cardiac lymphoma: B- and T-cell cases at a specialist UK Centre. Ann Oncol. 2010;21(5):1041–1045.
- Schoen FJ, Berger BM, Guerina NG. Cardiac effects of noncardiac neoplasms. Cardiol Clin. 1984;2(4):657–670.
- Seymour JF, Kipps TJ, Eichhorst B, et al. Venetoclax-rituximab in relapsed or refractory chronic lymphocytic leukemia. N Engl J Med. 2018;378(12):1107–1120.
- Reynen K, Köckeritz U, Strasser RH. Metastases to the heart. Ann Oncol. 2004;15(3):375–381.
- Zhao Y, Huang S, Ma C, et al. Clinical features of cardiac lymphoma: an analysis of 37 cases. J Int Med Res. 2021;49(3) 00060521999558
- Danilova OV, Danilov AV. Pericardial involvement by chronic lymphocytic leukemia/small lymphocytic lymphoma. Blood. 2015;126(3):424.
- Hwang YY, Fan K, Lam YM, et al. Primary cardiac lymphoma presenting with right heart mass and bradycardia. Ann Hematol. 2007;86(9):685–686.